FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080321830> ?p ?o ?g. }

• W2080321830 endingPage "159" @default.
• W2080321830 startingPage "153" @default.
• W2080321830 abstract "We now attempted to differentiate effects of cysteinyl-leukotrienes and leukotriene B4 on antigen-induced pulmonary reaction by using a selective leukotriene D4/E4 (CysLT1) receptor antagonist and a selective LTB4 (BLT) receptor antagonist in rats. An intratracheal challenge with ovalbumin to Brown-Norway rats actively sensitized with ovalbumin produced two phases of airway responses which were estimated based on airway resistance, the immediate-type airway response within 30 min, and the delayed-type airway response beginning from 4 to 6 h after the challenge. Pretreatment of the rats with a CysLT1 receptor antagonist (pranlukast) failed to reduce the elevation of airway resistance, and pretreatment with a BLT receptor antagonist (ONO-4057; 5-[2-(2-carboxyethyl)-3-[6-(4-methoxyphenyl)-5E-hexenyl]- oxyphenoxy] valeric acid) also produced no decrease. In contrast, combined pretreatment of the rats with pranlukast and ONO-4057 did not reduce the amplitude of the immediate-type airway response, but did allow the elevated airway resistance to return to its baseline level and also significantly inhibited the delayed-type airway response. Histological examination at 6 h after ovalbumin challenge showed infiltration of inflammatory cells with a predominance of neutrophils and scattered eosinophils in the bronchial submucosa. While pretreatment with neither pranlukast nor with ONO-4057 inhibited the infiltration of inflammatory cells in the bronchial submucosa, pretreatment with the two antagonists combined significantly inhibited the infiltration of granulocytes into the bronchial submucosa. On the contrary, intratracheal administration of either leukotriene D4 or leukotriene B4 up to 10 microg resulted in the infiltration of granulocytes into the bronchial submucosa, but no synergism for the infiltration of granulocytes was observed after combined administration. These results suggest that leukotriene B4 appears to play a significant role in the antigen-induced pulmonary reaction in association with cysteinyl-leukotrienes. Accordingly, the combined antagonism at the CysLT1 receptor and BLT receptor may be a useful intervention for the treatment of bronchial asthma." @default.
• W2080321830 created "2016-06-24" @default.
• W2080321830 creator A5005871579 @default.
• W2080321830 creator A5014583641 @default.
• W2080321830 creator A5055953176 @default.
• W2080321830 creator A5061614629 @default.
• W2080321830 creator A5087289588 @default.
• W2080321830 date "1999-04-01" @default.
• W2080321830 modified "2023-09-23" @default.
• W2080321830 title "Synergistic effects of pranlukast and a leukotriene B4 receptor antagonist on antigen-induced pulmonary reaction" @default.
• W2080321830 cites W1556559565 @default.
• W2080321830 cites W1598873296 @default.
• W2080321830 cites W1900718892 @default.
• W2080321830 cites W1971569966 @default.
• W2080321830 cites W1978685949 @default.
• W2080321830 cites W1985405157 @default.
• W2080321830 cites W1988812540 @default.
• W2080321830 cites W1990277484 @default.
• W2080321830 cites W1997059359 @default.
• W2080321830 cites W2007323623 @default.
• W2080321830 cites W2014982517 @default.
• W2080321830 cites W2023213942 @default.
• W2080321830 cites W2028746513 @default.
• W2080321830 cites W2039637501 @default.
• W2080321830 cites W2047190988 @default.
• W2080321830 cites W2049796670 @default.
• W2080321830 cites W2054795208 @default.
• W2080321830 cites W2058661991 @default.
• W2080321830 cites W2060929861 @default.
• W2080321830 cites W2068361114 @default.
• W2080321830 cites W2090063667 @default.
• W2080321830 cites W2104505088 @default.
• W2080321830 cites W2123186852 @default.
• W2080321830 cites W2124364562 @default.
• W2080321830 cites W2146156454 @default.
• W2080321830 cites W4248988756 @default.
• W2080321830 doi "https://doi.org/10.1016/s0014-2999(99)00126-0" @default.
• W2080321830 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10323264" @default.
• W2080321830 hasPublicationYear "1999" @default.
• W2080321830 type Work @default.
• W2080321830 sameAs 2080321830 @default.
• W2080321830 citedByCount "11" @default.
• W2080321830 crossrefType "journal-article" @default.
• W2080321830 hasAuthorship W2080321830A5005871579 @default.
• W2080321830 hasAuthorship W2080321830A5014583641 @default.
• W2080321830 hasAuthorship W2080321830A5055953176 @default.
• W2080321830 hasAuthorship W2080321830A5061614629 @default.
• W2080321830 hasAuthorship W2080321830A5087289588 @default.
• W2080321830 hasConcept C105922876 @default.
• W2080321830 hasConcept C126322002 @default.
• W2080321830 hasConcept C147483822 @default.
• W2080321830 hasConcept C153400128 @default.
• W2080321830 hasConcept C159985019 @default.
• W2080321830 hasConcept C170493617 @default.
• W2080321830 hasConcept C185592680 @default.
• W2080321830 hasConcept C192562407 @default.
• W2080321830 hasConcept C203014093 @default.
• W2080321830 hasConcept C2776042228 @default.
• W2080321830 hasConcept C2776452501 @default.
• W2080321830 hasConcept C2776685179 @default.
• W2080321830 hasConcept C2776885963 @default.
• W2080321830 hasConcept C2776914184 @default.
• W2080321830 hasConcept C2776946954 @default.
• W2080321830 hasConcept C2777242621 @default.
• W2080321830 hasConcept C2778122271 @default.
• W2080321830 hasConcept C2780212800 @default.
• W2080321830 hasConcept C33362165 @default.
• W2080321830 hasConcept C42219234 @default.
• W2080321830 hasConcept C71924100 @default.
• W2080321830 hasConcept C98274493 @default.
• W2080321830 hasConceptScore W2080321830C105922876 @default.
• W2080321830 hasConceptScore W2080321830C126322002 @default.
• W2080321830 hasConceptScore W2080321830C147483822 @default.
• W2080321830 hasConceptScore W2080321830C153400128 @default.
• W2080321830 hasConceptScore W2080321830C159985019 @default.
• W2080321830 hasConceptScore W2080321830C170493617 @default.
• W2080321830 hasConceptScore W2080321830C185592680 @default.
• W2080321830 hasConceptScore W2080321830C192562407 @default.
• W2080321830 hasConceptScore W2080321830C203014093 @default.
• W2080321830 hasConceptScore W2080321830C2776042228 @default.
• W2080321830 hasConceptScore W2080321830C2776452501 @default.
• W2080321830 hasConceptScore W2080321830C2776685179 @default.
• W2080321830 hasConceptScore W2080321830C2776885963 @default.
• W2080321830 hasConceptScore W2080321830C2776914184 @default.
• W2080321830 hasConceptScore W2080321830C2776946954 @default.
• W2080321830 hasConceptScore W2080321830C2777242621 @default.
• W2080321830 hasConceptScore W2080321830C2778122271 @default.
• W2080321830 hasConceptScore W2080321830C2780212800 @default.
• W2080321830 hasConceptScore W2080321830C33362165 @default.
• W2080321830 hasConceptScore W2080321830C42219234 @default.
• W2080321830 hasConceptScore W2080321830C71924100 @default.
• W2080321830 hasConceptScore W2080321830C98274493 @default.
• W2080321830 hasIssue "2" @default.
• W2080321830 hasLocation W20803218301 @default.
• W2080321830 hasLocation W20803218302 @default.
• W2080321830 hasOpenAccess W2080321830 @default.
• W2080321830 hasPrimaryLocation W20803218301 @default.
• W2080321830 hasRelatedWork W1017640680 @default.

• next